"10.1371_journal.pone.0061432","plos one","2013-04-22T00:00:00Z","Richard Smith; Amy Duguay; Alice Bakker; Peng Li; Jennifer Weiszmann; Melissa R Thomas; Benjamin M Alba; Xinle Wu; Jamila Gupte; Li Yang; Jennitte Stevens; Agnes Hamburger; Stephen Smith; Jiyun Chen; Renee Komorowski; Kevin W Moore; Murielle M VÃ©niant; Yang Li","Therapeutic Discovery, Amgen Inc., South San Francisco, California, United States of America; Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America; Therapeutic Discovery, Amgen Inc., Thousand Oaks, California, United States of America; Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, California, United States of America; Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America","Conceived and designed the experiments: RS AD AB KWM MMV YL. Performed the experiments: RS AD AB PL JW MRT BMA XW JG LY JS SS. Analyzed the data: RS AD AB JW XW JS RK MMV YL. Contributed reagents/materials/analysis tools: PL MRT BMA AH SS JC. Wrote the paper: RS YL.","All authors are employees and shareholders of Amgen, Inc. The Avimer sequences described in this publication are also described in the pending patent US20110150901. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Richard Smith","RS",18,TRUE,6,12,9,2,TRUE,TRUE,FALSE,0,NA,FALSE
